CN
109-99-9
应用筛选条件
关键词:'109-99-9'
显示 1-30 共 223 条结果 关于 "109-99-9" 范围 技术文档
The Effective Use of Protein Kinase Inhibitors
117 87 104 91 100 44 32 103 96 93 57 54 20
LCK 76 109 94 70 92 87 99 85 32 37 95 85 83 102 99 105 79 86 86
CHK1 21 99 82 107
The Effective Use of Protein Kinase Inhibitors
117 87 104 91 100 44 32 103 96 93 57 54 20
LCK 76 109 94 70 92 87 99 85 32 37 95 85 83 102 99 105 79 86 86
CHK1 21 99 82 107
Quality Control Ranges: MILLIPLEX® MAP Mouse Cytokine/Chemokine Panel
pg/mL TNF Control 1 109 - 227 pg/mL
Control 2 497 - 1032 pg/mL Control 2 502 - 1042 pg/mL Control 2 464 - 963 pg/mL
IL-2 Control 1 100
Data Sheet - 76307
Leipzig, 109, 52 (1982).
5. Markwardt, F. et al., Biochem. Pharmac., 23, 2247 (1974).
6. Baker, B.R. and Cory, M., J. Med. Chem. 14, 119 (1971)
7. W.B: Lawson, et al., Folia Haematol. 109, 52 (1982)
Quality Control Ranges - Milliplex Mouse Cytokine/Chemokine Magnetic Panel
Range Units Cytokine QC Level Expected Range Units
G-CSF Control 1 104 - 216 pg/mL IL-9 Control 1 99 - 206 pg/mL MIP-1 Control 1 108 - 224 pg/mL
Control 2
Data Sheet - T5411 - Lot 060K88021
5000
10000
15000
20000
25000
30000
35000
m/z
Abundance
41
55
79
91
109
124
147
165 187
203
228
246
260
273
288
Product Information Sheet - I2396
References
1. Ryff, J.C., Usefulness of interferon for treatment of
hepatitis C. J. Hepatol., 22, 101-109 (1995).
2. Dusheiko, G.M., and Roberts, J.A., Treatment of
Chronic Type B and C Hepatitis with Alpha
Data Sheet - S5174
Chem., 267,
16736-16745 (1992)
8. Raines, E.W. et al., 89, 1281-1285 (1992)
9. a. Termine, J.D. et al., Cell, 26, 99-105 (1981)
b. Lane, T.F. and Sage, E.H., J. Cell Biol., 111,
3065-3076 (1990)
PIC002 ReadyShield Protease Inhibitor Cocktail
stored at 2-8 °C.
References
1. Umezawa H., Ann. Rev. Microbiol., 36, 75-99
(1982).
2. Aoyagi, T., et al, Biochem. Int., 9, 405-411 (1984).
3. Aoyagi T., and Umezawa, H., Acta Biol. Med. Ger.
Product Information Sheet - A9673
at
10 mg/ml in 98% ethanol.7 Solubility of 109 mg of
arachidonic acid in 1 ml absolute ethanol gave a clear,
colorless solution, but further dilution with 9 volumes of
phosphate buffered saline gave
Product Information Sheet - A5394
1980).
8. Wilson, J.E. and Chin A., Analytical Biochem., 193, 16 (1991).
9. Solheim, L.P. and Fromm H.J., Analytical Biochem., 109, 266 (1980).
10. McCarty, R.E., Analytical Biochem., 205, 371 (1992).
11
Product Information Sheet - A6144
1980).
8. Wilson, J.E. and Chin A., Analytical Biochem., 193, 16 (1991).
9. Solheim, L.P. and Fromm H.J., Analytical Biochem., 109, 266 (1980).
10. McCarty, R.E., Analytical Biochem., 205, 371 (1992).
11
Product Information Sheet - A3147
1980).
8. Wilson, J.E. and Chin A., Analytical Biochem., 193, 16 (1991).
9. Solheim, L.P. and Fromm H.J., Analytical Biochem., 109, 266 (1980).
10. McCarty, R.E., Analytical Biochem., 205, 371 (1992).
11
Monitoring low dose API blend uniformity with Parteck® M
: Partial least square.
69 75 81 87 93 99
Lab data
Calibration Set: Calculated vs Lab Data
105 111 117 123 129 135
129
135
123
117
111
105
99
M
od
el
p
re
di
Product Information Sheet - A3555
at
10 mg/ml in 98% ethanol.7 Solubility of 109 mg of
arachidonic acid in 1 ml absolute ethanol gave a clear,
colorless solution, but further dilution with 9 volumes of
phosphate buffered saline gave
Product Information Sheet - T8532
, Y. and Catrovas, G.N., Anal. Biochem.,
109, 55-62 (1980).
8. Enzymes of Molecular Biology, M.M. Burrell, Ed.
(Humana Press, NJ, 1993), p. 307.
9. Supplier method, based on work by Crabb, N.T
Product Information Sheet - A3925
at
10 mg/ml in 98% ethanol.7 Solubility of 109 mg of
arachidonic acid in 1 ml absolute ethanol gave a clear,
colorless solution, but further dilution with 9 volumes of
phosphate buffered saline gave
Product Information Sheet - C7988
212 (1997).
2. Tsien, J. Z., et al., Cell, 87, 1317-1326 (1996).
3. Nagy, A., Genesis, 26, 99-109 (2000).
4. Rajewsky, K., et al., J. Clin. Invest., 98, 600-603
(1996).
TWEEN is a registered
Data Sheet - R4777
288, 1374-1377 (2000).
3. Nakielny, S., and Dreyfuss, G., Cell, 99, 677-690
(1999).
4. Avis, J.M., and Clarke, P.R., J. Cell Sci., 109,
2423-2427 (1996).
5. Rexach, M., and Blobel, G., Cell
DataSheet - P4744
, 3rd ed. (Rose, N.R.
et al., eds.). American Society for Microbiology
(Washington, D.C.), pp. 99-109 (1986).
4. Guo, Shuai, "Development of a DNA vaccine
inducing HIV-1 Gagp24-reactive T cells"
Collagens for Cell Culture
59(4): 538-548.
9. Yaffe, D. (1973). Rat Skeletal Muscle Cells. In: Tissue Culture: Methods and Applications. Kruse, P. and Patterson, M. (eds). New
York Academic Press, pp 106-109.
10. Yamada, K.
Collagens for Cell Culture
59(4): 538-548.
9. Yaffe, D. (1973). Rat Skeletal Muscle Cells. In: Tissue Culture: Methods and Applications. Kruse, P. and Patterson, M. (eds). New
York Academic Press, pp 106-109.
10. Yamada, K.
Collagens for Cell Culture
59(4): 538-548.
9. Yaffe, D. (1973). Rat Skeletal Muscle Cells. In: Tissue Culture: Methods and Applications. Kruse, P. and Patterson, M. (eds). New
York Academic Press, pp 106-109.
10. Yamada, K.
Collagens for Cell Culture
59(4): 538-548.
9. Yaffe, D. (1973). Rat Skeletal Muscle Cells. In: Tissue Culture: Methods and Applications. Kruse, P. and Patterson, M. (eds). New
York Academic Press, pp 106-109.
10. Yamada, K.
Collagens for Cell Culture
59(4): 538-548.
9. Yaffe, D. (1973). Rat Skeletal Muscle Cells. In: Tissue Culture: Methods and Applications. Kruse, P. and Patterson, M. (eds). New
York Academic Press, pp 106-109.
10. Yamada, K.
Collagens for Cell Culture
59(4): 538-548.
9. Yaffe, D. (1973). Rat Skeletal Muscle Cells. In: Tissue Culture: Methods and Applications. Kruse, P. and Patterson, M. (eds). New
York Academic Press, pp 106-109.
10. Yamada, K.
Product Information Sheet - N9389
, 3rd ed. (Rose, N.R.
et al., eds.). American Society for Microbiology
(Washington, D.C.), pp. 99-109 (1986).
4. Wei, J.S. et al., Clin. Chem., 39(3), 540-543
(1993).
5. Gioria, R. et al., Plant
Collagens for Cell Culture
59(4): 538-548.
9. Yaffe, D. (1973). Rat Skeletal Muscle Cells. In: Tissue Culture: Methods and Applications. Kruse, P. and Patterson, M. (eds). New
York Academic Press, pp 106-109.
10. Yamada, K.
Verfication summary-03-0202-00
SD CV
Spike
Recovery
HMN713784
3 0.0
25
86.22 2.1 2% -
3 150.0 234.01 22.2 9% 99%
3 75.0 184.32 5.1 3% 131%
3 37.5 146.03 5.7 4%
Verfication summary-03-0202-00
SD CV
Spike
Recovery
HMN713784
3 0.0
25
86.22 2.1 2% -
3 150.0 234.01 22.2 9% 99%
3 75.0 184.32 5.1 3% 131%
3 37.5 146.03 5.7 4%
1/8